Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017 Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …
News
money-2180330_960_720

Latest US company accused of price gouging, after 2,469% increase

December 12, 2017 Manufacturing and Production, Sales and Marketing Avondale Pharmaceutical, Niacor, biotech, drugs, pharma, pharmaceutical

It seems that no matter how much bad press comes their way, certain pharmaceutical companies are more than happy to …
News
shutterstock_212035546

Single, high-dose vaccine could provide better protection against cholera outbreaks, new research shows

December 12, 2017 Manufacturing and Production, Research and Development Africa, Asia, Caribbean, Cholera, Vaccine, paxvax, pharma

A team of researchers at the University of Maryland School of Medicine (UMSOM) has been assessing the effectiveness of a …
News
sanofi_new_paris_hq

Sanofi issues US-wide recall for arthritis product, after adverse events

December 12, 2017 Manufacturing and Production Sanofi, Synvisc-One, biotech, drugs, pharma, pharmaceutical

Sanofi has announced a recall of 12,380 syringes of its Synvisc-One product for the treatment of osteoarthritis, after it was …
News
brainss

Ionis scores huge breakthrough in Huntington’s, Roche licenses drug

December 12, 2017 Manufacturing and Production, Research and Development Ionis, Roche, biotech, drugs, pharma, pharmaceutical

Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …
News

Exscientia appoints Oxford Innovation Sciences founder and ex-Lansdowne CEO as Deputy Chairman

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Snow, Exscientia, appointment

Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …
Appointment
hands-600497_960_720

To succeed in emerging market medicine, anticipation and innovation are essential

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …
Feature
teva_small

Teva job cut rumours resurface, 10,000 expected

December 11, 2017 Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have …
News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, most read news, pharma, pharmaceutical, top ten

Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …
News
james-levine-11206608

Fondation Ipsen announces Dr James Levine as new President

December 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fondation Ipsen has announced its appointment of Dr James A Levine as its new President. The organisation was set up …
Appointment
dna-163466

Getting precision treatments over the line will be a team effort, not an individual bolt for glory

December 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prostate Cancer UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …
Feature
novo_flag

Novo Nordisk unveils hard-hitting data for two of its diabetes therapies

December 5, 2017 Manufacturing and Production, Research and Development Novo Nordisk, Tresiba, Xultophy, diabetes, pharma

Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …
News
vanilla-flower-542019_960_720

Vanilla compound found to prevent psoriasis

December 5, 2017 Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical, psoriasis, vanilla

Psoriasis is a big pharmaceutical market, it’s the most common autoimmune disease in the US and as many as 7.5 …
News
nhs_sign

NHS talking therapies for mental health hit a high with 1.4 million referrals

December 5, 2017 Manufacturing and Production, Medical Communications NHS, anxiety, depression, mental illness, pharma

New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …
News

AbbVie posts strong psoriasis data but can it stand out from crowd?

December 5, 2017 Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical

AbbVie revealed that its IL-23 inhibitor, risankizumab, had successfully met all of its endpoints in a Phase 3 trials into …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026